Tennessee ophthalmologists dispute legislation allowing ODs to use injectable anesthesia

Article

The Tennessee Academy of Ophthalmology (TNAO) is opposing a recently filed bill (SB220/HB555) that, as amended, would allow optometrists to inject local anesthesia into the tissue surrounding the eye in order to perform surgery.

Nashville, TN-The Tennessee Academy of Ophthalmology (TNAO) is opposing a recently filed bill (SB220/HB555) that, as amended, would allow optometrists to inject local anesthesia into the tissue surrounding the eye in order to perform surgery.

The legislation would expand optometrists’ scope of practice to allow them to inject anesthesia into the tissues surrounding the eyelid. Under the legislation, optometrists would be permitted to perform more advanced surgical procedures that require an injectable anesthetic.

“This legislation would create an unnecessary risk to patients and is a threat to the quality of surgical care in Tennessee,” said Ben Mahan, MD, president of the TNAO. “Anytime a needle is placed near the eye, there are serious risks to the patient that require clinical experience and expert judgment. A surgical error of just a few millimeters can result in a punctured eyeball and catastrophic vision loss.

“Whether it is injections to prepare for surgery or the surgery itself, patients have a right to know that the individual performing the procedure is a qualified medical doctor and surgeon,” Dr. Mahan said.

See the upcoming April issue of Optometry Times for deeper coverage on the Tennesee bill.

Read the original story

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.